Since the discovery of IGFBP3 as a p53-inducible gene in 1995 [68], studies in many cancer cell lines have demonstrated an increase in the expression of IGFBP-3 in response to treatment by chemotherapeutic drugs [69–71]. This evidence concerns the gene IGFBP3 and cancer.